Status: Active

Supira Medical

  • Status Current
  • Sector Heart Failure
  • Year Invested 2020
  • HQ Campbell, CA, United States
  • Clinical Activities Brazil, Paraguay
  • Lead Partners Frederik Groenewegen
  • David Thompson


Related News

Percutaneous heart pump for high risk PCI and cardiogenic shock patients

Percutaneous ventricular assist devices are used during stent placement or angioplasty to provide mechanical support for high-risk patients with severe coronary artery disease or comorbidities. Additionally, pVADs are used to treat patients suffering from cardiogenic shock (CS), a condition that can occur following a severe heart attack and is associated with a high rate of morbidity as a patient's heart is suddenly too weak to adequately pump blood to vital organs.